FINANCIALS

LYEL Lyell Immunopharma Inc 1806952

Income Statement
Revenue	lyel-20241231	34,000
Net Income	lyel-20241231	-44,583,000
Profit Margin		-131126.47%

Balance Sheet
Current Assets	450,045,000
Assets	619,215,000
Current Liabilities	33,512,000
Liabilities	88,518,000
Equity	530,697,000

Cash Flow Statement
Operating Cash Flow	-115,152,000
Investing Cash Flow	68,919,000

Market Analysis
Price	0.57
BVPS	10.67
PB	0.05
PS	2.49
FCF	-46,233,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view LYEL documents filed with the SEC.

LYEL Filings Clear

View A List of Tickers